What is it about?
Ziconotide has potential to be a first-line alternative to morphine .Ziconotide (initiated using a low-dose, slow-titration approach) is suitable for many patients with noncancer- or cancer-related chronic refractory pain and no history of psychosis, reducing opioid usage in these patient populations
Featured Image
Why is it important?
The article underline the importance in using a non opioid intrathecal analgesic
Perspectives
The spread of knowledge of intrathecal ziconotide could increase yhe use of intrathecal treatment without using opioids
Pasquale De Negri
AZIENDA OSPEDALIERA S.ANNA & S.SEBASTIANO, CASERTA
Read the Original
This page is a summary of: Intrathecal pain management with ziconotide: Time for consensus?, Brain and Behavior, March 2021, Wiley,
DOI: 10.1002/brb3.2055.
You can read the full text:
Contributors
The following have contributed to this page
